Skip to main content

Table 1 Antibiotic susceptibility results of the tested isolates

From: Trends in antibiotic susceptibility patterns and epidemiology of MRSA isolates from several hospitals in Riyadh, Saudi Arabia

Antibiotic

Total susceptibility No. (%) (512)

Inpatient isolates No. (%) (397)

Outpatient isolates No. (%) (115)

Vancomycin

512(100)

397(100)

115(100)

Quinupristin/dalfopristin

512(100)

397(100)

115(100)

Linezolid

491(95.9)

386(97.2)

105(91.3)

Chloramphenicol

413(80.7)

302(76.1)

111(96.5)

Gatifloxacin

404(78.9)

299(75.3)

105(91.3)

Mupirocin

394(77.0)

292(73.6)

102(88.7)

Gentamicin

203(39.6)

118(29.7)

85(73.9)

Sulfamethoxazole/trimethoprim

173(33.8)

85(21.4)

88(76.5)

Fusidic acid

22(4.3)

15(3.8)

7(6.1)